Join Your Analytical Community in Boston in 2022!
The 3rd Cell Therapy Analytical Development Summit returned in December 2021 as the leading industry-defining forum made exclusively for analytical, CMC, QC, and process development experts.
New for 2021, two tracks of content showcasing:
- Automated analytical processes to reduce turnaround time
- Strategies to validate novel assays for next generation therapies
- New genomic testing technology to gain a deeper understanding of the cell product
- Experience in navigating regulatory guidelines to reduce delays
… To equip your team with the lessons learned to achieve success in analytical submission from IND through to commercialization.
Learnings came from analytical trailblazers at bluebird bio, BMS, Kite, Novartis and more to support your efforts in developing safe and effective cell therapies. Download the 2021 event guide to learn more on what you missed.
“A breakthrough summit that enables a discussion on emerging needs in the analytical development arena.”
Scientist, CRISPR Therapeutics
“Great content and exposure to the latest progress being made in the field.”
Director - Potency, Analytical, Cell Based Assay, Center Excellence & Biologics Bioprocess, Merck
“A huge highlight of my year and the key connections I made will allow for fruitful collaborations and sharing of ideas that will be valuable for years to come.”
Biomedical Engineer, National Institute of Standards & Technology, NIST
“I felt this was an incredibly valuable experience to hear the shared challenges and new solutions in our industry.”
Research Associate, BMS
Your World Class Speakers
The health, safety and well-being of our community remains our highest priority. Therefore, all attendees will be required to complete a health declaration prior to attending the event. As part of this, attendees must declare that they are either fully vaccinated and /or have completed a negative Lateral Flow Test or PCR Test within 48 hours the event*. For further information around Health and Safety onsite, please visit our FAQ here.
*Please note, this is subject to change at any time without prior notice.